23-Feb-2010 - Aesica is looking to acquire manufacturing assets in the US to expand its client base in the country and continue the growth it has maintained throughout the economic downturn.
22-Feb-2010 - The Chinese API sector shrank last year after a number of high profile quality problems hit demand from Western markets, according to new analysis by outsourcing consultant JZ Med.
22-Feb-2010 - RecipharmCobra Biologics (RCB) launched today as a specialist biologics contract development and manufacturing organization (CDMO).
18-Feb-2010 - Contract API maker Ampac Fine chemicals (AFC) has had a busy 24-hours, entering the Japanese market through a deal with Inabata and forging an alliance with Codexis on biocatalyst technology.
18-Feb-2010 - Asian companies have come of age as ingredient suppliers and manufacturers but the region still suffers from promises of unrealistic timelines and a poor supply chain, according to a panel at Informex 2010.
17-Feb-2010 - Communication is a vital aspect of the relationship between CMOs, CROs and their clients, with a single point of contact who quickly informs sponsors of problems a necessity, according to a panel at Informex 2010.
15-Feb-2010 - GEA Niro says new spray drying deal with BASF is an important step in the development of its recently established contract API manufacturing unit.
11-Feb-2010 - Cambrex reported a dip in revenues in 2009, citing the timing of orders throughout the year, and warned that smaller clients’ funding difficulties and pricing pressures will continue in 2010.
11-Feb-2010 - US CDMO Avrio Biopharmaceuticals’ new aseptic fill-and-finish facility in Irvine, California has been approved for the manufacture of biologics by state drug regulators.
10-Feb-2010 - Almac Pharma Services has bolstered its product development offering with a new Xcelodose 600s precision powder micro-dosing system that, it claims, can cut processing time, API usage and costs.
10-Feb-2010 - UK CMO SCM Pharma says a grant from UKTI is a boost for expansion plans and efforts to win clients in key pharmaceutical industry R&D hubs.
08-Feb-2010 - ISCO’s stem cell manufacturing facility has passed final building inspection, enabling it to implement the processes and cGMP standards needed to produce clinical-grade products.
04-Feb-2010 - Pharmadule has teamed up with Morimatsu to capture a share of Chinese pharma and biotech manufacturing markets’ “huge potential.”
03-Feb-2010 - Demand for disposable bioprocessing tech helped Millipore to a comfortable Q4, cementing the recovery made by the unit throughout 2009.
02-Feb-2010 - Suzhou Erye Pharmaceutical has received SFDA approval to make penicillin at its new manufacturing facility in Eastern China.
02-Feb-2010 - LFB Biomedicaments has awarded Thrapure Biopharma a protein manufacturing contract that will see the Canadian CDMO install new production capacity at its facility in Toronto.
01-Feb-2010 - US generics group Watson Pharmaceuticals has bought UK contract biomanufacturing specialist Eden Biodesign.
01-Feb-2010 - Contract services major Quintiles will sell Movetis’ chronic constipation treatment Resolor (prucalopride) in Europe under a contract announced last week.
01-Feb-2010 - Peakdale Molecular and Pfizer unveil plan set up a synthetic chemistry services group just days after the US major trimmed its pipeline.
01-Feb-2010 - Therapure Biopharma has added commercial-scale lyophilisation capacity at its facility Mississauga, Ontario in response to growing demand.
29-Jan-2010 - AstraZeneca will cut 8,000 more jobs by 2014 with R&D and supply chain operations being the main focus of the cutbacks.
28-Jan-2010 - Full-year income at the Lonza was hit by falling demand for life science ingredients and custom manufacturing services and only modest gains for its bioscience unit.
27-Jan-2010 - Environmental certification of production facilities should be introduced to GMP legislation and sustainability risk assessments linked to marketing authorisations, according to a MPA report.
27-Jan-2010 - Merck KGaA has begun work on a new inorganic salts plant in Darmstadt, Germany, citing growing demand as the main motivation for the €30m ($42m) investment.
27-Jan-2010 - Recipharm says acquisition of German CMO Wasserburger Arzneimittelwerk from Hospira adds large-scale lyophilisation services to its offering.